Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001387131-19-003915
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-23 19:09:00
Reporting Period:
2019-05-22
Accepted Time:
2019-05-23 19:09:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1528557 Corindus Vascular Robotics Inc. CVRS Surgical & Medical Instruments & Apparatus (3841) 300687898
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1700257 A Louis Cannon 309 Waverley Oaks Road, Suite 105
Waltham MA 02452
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-22 7,500 $2.63 299,767 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 7,557,436 Indirect See Footnote
Common Stock 573,798 Indirect See Footnote
Footnotes
  1. The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.6266 to $2.63, inclusive. The reporting person undertakes to provide Corindus Vascular Robotics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. Includes 53,326 shares of common stock related to restricted stock units (RSUs) granted as part of the director's 2018 annual equity award. The RSUs provide for vesting in quarterly installments on August 31, 2018, November 30, 2018, February 28, 2019 and May 31, 2019, subject to the reporting person's continuous service with the Company through each such vesting date.
  3. Includes 27,649 shares of common stock related to RSUs granted as part of the director's 2019 annual equity award. The RSUs provide for vesting in quarterly installments on August 3, 2019, November 3, 2019, February 3, 2020 and May 3, 2020, subject to the reporting person's continuous service with the Company through each such vesting date.
  4. 175,801 shares are held in Cardiac & Vascular Research Center 401k FBO Louis A Cannon; the remaining shares are held directly.
  5. Consists of securities directly owned by BioStar Ventures III, L.P. Dr. Cannon is the founder and Senior Managing Director of BioStar Ventures III, L.P., and, as such, may be deemed to beneficially own the securities held of record by BioStar Ventures III, L.P. for purposes of Rule 16a-1(a). Dr. Cannon disclaims any beneficial ownership of the securities reported, except to the extent of any pecuniary interest therein.
  6. Consists of securities directly owned by BioStar Ventures III-XF, L.P. Dr. Cannon is the founder and Senior Managing Director of BioStar Ventures III-XF, L.P., and, as such, may be deemed to beneficially own the securities held of record by BioStar Ventures III-XF, L.P. for purposes of Rule 16a-1(a). Dr. Cannon disclaims beneficial ownership of the securities reported, except to the extent of any pecuniary interest therein.